-
1
-
-
84871055775
-
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010
-
PID: 23245609
-
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2224–60.
-
(2012)
Lancet
, vol.380
, pp. 2224-2260
-
-
Lim, S.S.1
Vos, T.2
Flaxman, A.D.3
Danaei, G.4
Shibuya, K.5
Adair-Rohani, H.6
-
2
-
-
79959334521
-
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High bBlood Pressure Research
-
PID: 18574054
-
Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High bBlood Pressure Research. Circulation. 2008;117:e510–26.
-
(2008)
Circulation
, vol.117
, pp. e510-e526
-
-
Calhoun, D.A.1
Jones, D.2
Textor, S.3
Goff, D.C.4
Murphy, T.P.5
Toto, R.D.6
-
3
-
-
84878905384
-
Resistant hypertension and target organ damage
-
PID: 23595044
-
Muiesan ML, Salvetti M, Rizzoni D, Paini A, Agabiti-Rosei C, Aggiusti C, Agabiti Rosei E. Resistant hypertension and target organ damage. Hypertens Res. 2013;36:485–91.
-
(2013)
Hypertens Res
, vol.36
, pp. 485-491
-
-
Muiesan, M.L.1
Salvetti, M.2
Rizzoni, D.3
Paini, A.4
Agabiti-Rosei, C.5
Aggiusti, C.6
Agabiti Rosei, E.7
-
4
-
-
84859424203
-
Incidence and prognosis of resistant hypertension in hypertensive patients
-
PID: 22379110
-
Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125:1635–42.
-
(2012)
Circulation
, vol.125
, pp. 1635-1642
-
-
Daugherty, S.L.1
Powers, J.D.2
Magid, D.J.3
Tavel, H.M.4
Masoudi, F.A.5
Margolis, K.L.6
-
5
-
-
85010073535
-
-
Lancet: Global action plan for improving BP management
-
•• Olsen, MH, Angell, SY, Asma, S, Boutouyrie, P, Burger, D, Chirinos, JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet 2016. Global action plan for improving BP management.
-
(2016)
MH, Angell, SY, Asma, S, Boutouyrie, P, Burger, D, Chirinos, JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension
-
-
Olsen1
-
6
-
-
84929253215
-
Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations
-
PID: 25156625
-
Achelrod D, Wenzel U, Frey S. Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. Am J Hypertens. 2015;28:355–61.
-
(2015)
Am J Hypertens
, vol.28
, pp. 355-361
-
-
Achelrod, D.1
Wenzel, U.2
Frey, S.3
-
7
-
-
84962276527
-
Resistant hypertension and the pivotal role for mineralocorticoid receptor antagonists: a clinical update 2016
-
PID: 26899747, Comprehensive review on the rationale for using mineralocorticoid receptor antagonists (eg spironolactone) in RH
-
• Epstein M, Duprez DA. Resistant hypertension and the pivotal role for mineralocorticoid receptor antagonists: a clinical update 2016. Am J Med. 2016;129:661–6. Comprehensive review on the rationale for using mineralocorticoid receptor antagonists (eg spironolactone) in RH
-
(2016)
Am J Med
, vol.129
, pp. 661-666
-
-
Epstein, M.1
Duprez, D.A.2
-
8
-
-
43449095741
-
The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome
-
COI: 1:CAS:528:DC%2BD1cXlslGls7w%3D, PID: 18475139
-
Nilsson PM, Lurbe E, Laurent S. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens. 2008;26:1049–57.
-
(2008)
J Hypertens
, vol.26
, pp. 1049-1057
-
-
Nilsson, P.M.1
Lurbe, E.2
Laurent, S.3
-
9
-
-
84880015206
-
2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
-
COI: 1:CAS:528:DC%2BC3sXhtVyksb%2FJ, PID: 23817082
-
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.
-
(2013)
J Hypertens
, vol.31
, pp. 1281-1357
-
-
Mancia, G.1
Fagard, R.2
Narkiewicz, K.3
Redón, J.4
Zanchetti, A.5
Böhm, M.6
-
10
-
-
84939230830
-
Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association
-
COI: 1:CAS:528:DC%2BC2MXhtlWhs77I, PID: 26160955, Detailed analysis of methods and recommendations for measuring arterial stiffness
-
• Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66:698–722. Detailed analysis of methods and recommendations for measuring arterial stiffness
-
(2015)
Hypertension
, vol.66
, pp. 698-722
-
-
Townsend, R.R.1
Wilkinson, I.B.2
Schiffrin, E.L.3
Avolio, A.P.4
Chirinos, J.A.5
Cockcroft, J.R.6
-
11
-
-
33750318148
-
Expert consensus document on arterial stiffness: methodological issues and clinical applications
-
PID: 17000623
-
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–05.
-
(2006)
Eur Heart J
, vol.27
, pp. 2505-2588
-
-
Laurent, S.1
Cockcroft, J.2
Van Bortel, L.3
Boutouyrie, P.4
Giannattasio, C.5
Hayoz, D.6
-
12
-
-
33745004785
-
Biomarkers of cardiovascular disease: molecular basis and practical considerations
-
PID: 16702488
-
Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006;113:2335–62.
-
(2006)
Circulation
, vol.113
, pp. 2335-2362
-
-
Vasan, R.S.1
-
13
-
-
66349111734
-
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association
-
PID: 19364974
-
Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408–16.
-
(2009)
Circulation
, vol.119
, pp. 2408-2416
-
-
Hlatky, M.A.1
Greenland, P.2
Arnett, D.K.3
Ballantyne, C.M.4
Criqui, M.H.5
Elkind, M.S.6
-
14
-
-
84937126409
-
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: endorsed by the Association for Research into arterial structure and physiology (ARTERY) society
-
COI: 1:CAS:528:DC%2BC2MXos1OgtL8%3D, PID: 26117398
-
Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cifkova R, Cosentino F, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: endorsed by the Association for Research into arterial structure and physiology (ARTERY) society. Atherosclerosis. 2015;241:507–32.
-
(2015)
Atherosclerosis
, vol.241
, pp. 507-532
-
-
Vlachopoulos, C.1
Xaplanteris, P.2
Aboyans, V.3
Brodmann, M.4
Cifkova, R.5
Cosentino, F.6
-
15
-
-
84896709653
-
Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects
-
PID: 24239664, Definitive study on the value of aortic stiffness in cardiovascular risk management
-
• Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63:636–46. Definitive study on the value of aortic stiffness in cardiovascular risk management
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 636-646
-
-
Ben-Shlomo, Y.1
Spears, M.2
Boustred, C.3
May, M.4
Anderson, S.G.5
Benjamin, E.J.6
-
16
-
-
77949557153
-
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis
-
PID: 20338492
-
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–27.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1318-1327
-
-
Vlachopoulos, C.1
Aznaouridis, K.2
Stefanadis, C.3
-
17
-
-
84857052856
-
Ambulatory arterial stiffness index does not accurately assess arterial stiffness
-
COI: 1:CAS:528:DC%2BC38XhvFams78%3D, PID: 22241142
-
Kips JG, Vermeersch SJ, Reymond P, Boutouyrie P, Stergiopulos N, Laurent S, et al. Ambulatory arterial stiffness index does not accurately assess arterial stiffness. J Hypertens. 2012;30:574–80.
-
(2012)
J Hypertens
, vol.30
, pp. 574-580
-
-
Kips, J.G.1
Vermeersch, S.J.2
Reymond, P.3
Boutouyrie, P.4
Stergiopulos, N.5
Laurent, S.6
-
18
-
-
0035997365
-
Methods and devices for measuring arterial compliance in humans
-
PID: 12160200
-
Pannier BM, Avolio AP, Hoeks A, Mancia G, Takazawa K. Methods and devices for measuring arterial compliance in humans. Am J Hypertens. 2002;15:743–53.
-
(2002)
Am J Hypertens
, vol.15
, pp. 743-753
-
-
Pannier, B.M.1
Avolio, A.P.2
Hoeks, A.3
Mancia, G.4
Takazawa, K.5
-
19
-
-
84857061063
-
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity
-
COI: 1:CAS:528:DC%2BC38XhvFanurY%3D, PID: 22278144
-
Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30:445–8.
-
(2012)
J Hypertens
, vol.30
, pp. 445-448
-
-
Van Bortel, L.M.1
Laurent, S.2
Boutouyrie, P.3
Chowienczyk, P.4
Cruickshank, J.K.5
De Backer, T.6
-
20
-
-
27444441183
-
Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff collaborative trial (ACCT)
-
PID: 16256881
-
McEniery CM, Yasmin X, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff collaborative trial (ACCT). J Am Coll Cardiol. 2005;46:1753–60.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1753-1760
-
-
McEniery, C.M.1
Yasmin, X.2
Hall, I.R.3
Qasem, A.4
Wilkinson, I.B.5
Cockcroft, J.R.6
-
21
-
-
67649873328
-
Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention
-
COI: 1:CAS:528:DC%2BD1MXntVyrt7s%3D, PID: 19487587
-
Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension. 2009;54:3–10.
-
(2009)
Hypertension
, vol.54
, pp. 3-10
-
-
Nilsson, P.M.1
Boutouyrie, P.2
Laurent, S.3
-
22
-
-
77957681696
-
‘establishing normal and reference values’
-
Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J 2010; 31:2338–2350.
-
(2010)
Eur Heart J
, vol.31
, pp. 2338-2350
-
-
-
23
-
-
84886435043
-
Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore longitudinal study of aging
-
COI: 1:CAS:528:DC%2BC3sXhs1amt7fK, PID: 24001897
-
AlGhatrif M, Strait JB, Morrell CH, Canepa M, Wright J, Elango P, et al. Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore longitudinal study of aging. Hypertension. 2013;62:934–41.
-
(2013)
Hypertension
, vol.62
, pp. 934-941
-
-
AlGhatrif, M.1
Strait, J.B.2
Morrell, C.H.3
Canepa, M.4
Wright, J.5
Elango, P.6
-
24
-
-
34250350040
-
2007 guidelines for the Management of Arterial Hypertension: the task force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
-
COI: 1:CAS:528:DC%2BD2sXmtlWnsr0%3D, PID: 17563527
-
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 guidelines for the Management of Arterial Hypertension: the task force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.
-
(2007)
J Hypertens
, vol.25
, pp. 1105-1187
-
-
Mancia, G.1
De Backer, G.2
Dominiczak, A.3
Cifkova, R.4
Fagard, R.5
Germano, G.6
-
25
-
-
67650517829
-
A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension
-
PID: 19444279
-
Castelpoggi CH, Pereira VS, Fiszman R, Cardoso CR, Muxfeldt ES, Salles GF. A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension. Hypertens Res. 2009;32:591–6.
-
(2009)
Hypertens Res
, vol.32
, pp. 591-596
-
-
Castelpoggi, C.H.1
Pereira, V.S.2
Fiszman, R.3
Cardoso, C.R.4
Muxfeldt, E.S.5
Salles, G.F.6
-
26
-
-
73349104970
-
Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review
-
COI: 1:CAS:528:DC%2BD1MXhtl2qurbO, PID: 19884567
-
Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54:1328–36.
-
(2009)
Hypertension
, vol.54
, pp. 1328-1336
-
-
Cecelja, M.1
Chowienczyk, P.2
-
27
-
-
84865701980
-
Aortic stiffness, blood pressure progression, and incident hypertension
-
COI: 1:CAS:528:DC%2BC38XhsFamtr7O, PID: 22948697
-
Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308:875–81.
-
(2012)
JAMA
, vol.308
, pp. 875-881
-
-
Kaess, B.M.1
Rong, J.2
Larson, M.G.3
-
28
-
-
84958553256
-
Central artery stiffness in hypertension and aging: a problem with cause and consequence
-
COI: 1:CAS:528:DC%2BC28XitVGqtb4%3D, PID: 26846637, Physiological rationale for a destructive positive feedback relationship between arterial stiffness and BP
-
• Humphrey JD, Harrison DG, Figueroa CA, Lacolley P, Laurent S. Central artery stiffness in hypertension and aging: a problem with cause and consequence. Circ Res. 2016;118:379–81. Physiological rationale for a destructive positive feedback relationship between arterial stiffness and BP
-
(2016)
Circ Res
, vol.118
, pp. 379-381
-
-
Humphrey, J.D.1
Harrison, D.G.2
Figueroa, C.A.3
Lacolley, P.4
Laurent, S.5
-
29
-
-
60149111841
-
Genetics and pathophysiology of arterial stiffness
-
COI: 1:CAS:528:DC%2BD1MXhvF2gsbw%3D, PID: 19098299
-
Lacolley P, Challande P, Osborne-Pellegrin M, Regnault V. Genetics and pathophysiology of arterial stiffness. Cardiovasc Res. 2009;81:637–48.
-
(2009)
Cardiovasc Res
, vol.81
, pp. 637-648
-
-
Lacolley, P.1
Challande, P.2
Osborne-Pellegrin, M.3
Regnault, V.4
-
30
-
-
84862903745
-
The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles
-
COI: 1:CAS:528:DC%2BC38XhtVSht77F, PID: 22467316
-
Lacolley P, Regnault V, Nicoletti A, Li Z, Michel JB. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res. 2012;95:194–204.
-
(2012)
Cardiovasc Res
, vol.95
, pp. 194-204
-
-
Lacolley, P.1
Regnault, V.2
Nicoletti, A.3
Li, Z.4
Michel, J.B.5
-
31
-
-
84930156225
-
The structural factor of hypertension: large and small artery alterations
-
COI: 1:CAS:528:DC%2BC2MXktlSisbw%3D, PID: 25767286
-
Laurent S, Boutouyrie P. The structural factor of hypertension: large and small artery alterations. Circ Res. 2015;116:1007–21.
-
(2015)
Circ Res
, vol.116
, pp. 1007-1021
-
-
Laurent, S.1
Boutouyrie, P.2
-
32
-
-
67651048925
-
Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial
-
COI: 1:CAS:528:DC%2BD1MXhtFaisLfP, PID: 19643310
-
Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol. 2009;54:505–12.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 505-512
-
-
Edwards, N.C.1
Steeds, R.P.2
Stewart, P.M.3
Ferro, C.J.4
Townend, J.N.5
-
33
-
-
84941228033
-
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design
-
PID: 25990344
-
Mahfoud F, Bohm M, Azizi M, Pathak A, Durand Zaleski I, Ewen S, et al. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. Eur Heart J. 2015;36:2219–27.
-
(2015)
Eur Heart J
, vol.36
, pp. 2219-2227
-
-
Mahfoud, F.1
Bohm, M.2
Azizi, M.3
Pathak, A.4
Durand Zaleski, I.5
Ewen, S.6
-
34
-
-
0027460281
-
An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man
-
COI: 1:STN:280:DyaK3s7ptlKrtw%3D%3D, PID: 8449191
-
Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J. 1993;14:160–7.
-
(1993)
Eur Heart J
, vol.14
, pp. 160-167
-
-
Karamanoglu, M.1
O'Rourke, M.F.2
Avolio, A.P.3
Kelly, R.P.4
-
35
-
-
84879417390
-
Central blood pressure in the management of hypertension: soon reaching the goal?
-
COI: 1:STN:280:DC%2BC3srgt1Cksw%3D%3D, PID: 23535990
-
Sharman JE, Laurent S. Central blood pressure in the management of hypertension: soon reaching the goal? J Hum Hypertens. 2013;27:405–11.
-
(2013)
J Hum Hypertens
, vol.27
, pp. 405-411
-
-
Sharman, J.E.1
Laurent, S.2
-
36
-
-
57049182971
-
Central blood pressure measurement may improve risk stratification
-
PID: 18596719
-
Sharman JE, Stowasser M, Fassett RG, Marwick TH, Franklin SS. Central blood pressure measurement may improve risk stratification. J Hum Hypertens. 2008;22:838–44.
-
(2008)
J Hum Hypertens
, vol.22
, pp. 838-844
-
-
Sharman, J.E.1
Stowasser, M.2
Fassett, R.G.3
Marwick, T.H.4
Franklin, S.S.5
-
37
-
-
45849141559
-
Central pressure: variability and impact of cardiovascular risk factors. The Anglo-Cardiff collaborative trial II
-
McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV, et al. Central pressure: variability and impact of cardiovascular risk factors. The Anglo-Cardiff collaborative trial II. Hypertension. 2008;6:1476–82.
-
(2008)
Hypertension
, vol.6
, pp. 1476-1482
-
-
McEniery, C.M.1
Yasmin2
McDonnell, B.3
Munnery, M.4
Wallace, S.M.5
Rowe, C.V.6
-
38
-
-
84950336508
-
Association of central versus brachial blood pressure with target-organ damage: systematic review and meta-analysis
-
PID: 26597821
-
Kollias A, Lagou S, Zeniodi ME, Boubouchairopoulou N, Stergiou GS. Association of central versus brachial blood pressure with target-organ damage: systematic review and meta-analysis. Hypertension. 2015;67:183–90.
-
(2015)
Hypertension
, vol.67
, pp. 183-190
-
-
Kollias, A.1
Lagou, S.2
Zeniodi, M.E.3
Boubouchairopoulou, N.4
Stergiou, G.S.5
-
39
-
-
0033613192
-
Association between local pulse pressure, mean blood pressure, and large-artery remodelling
-
COI: 1:STN:280:DyaK1MvjtFyhuw%3D%3D, PID: 10500038
-
Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodelling. Circulation. 1999;100:1387–93.
-
(1999)
Circulation
, vol.100
, pp. 1387-1393
-
-
Boutouyrie, P.1
Bussy, C.2
Lacolley, P.3
Girerd, X.4
Laloux, B.5
Laurent, S.6
-
40
-
-
0034612213
-
Local pulse pressure and regression of Arterial Wall hypertrophy during long-term antihypertensive treatment
-
COI: 1:CAS:528:DC%2BD3cXks1Sgsbo%3D, PID: 10840011
-
Boutouyrie P, Bussy C, Hayoz D, Hengstler J, Dartois N, Laloux B, et al. Local pulse pressure and regression of Arterial Wall hypertrophy during long-term antihypertensive treatment. Circulation. 2000;101:2601–6.
-
(2000)
Circulation
, vol.101
, pp. 2601-2606
-
-
Boutouyrie, P.1
Bussy, C.2
Hayoz, D.3
Hengstler, J.4
Dartois, N.5
Laloux, B.6
-
41
-
-
62249090188
-
The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification
-
COI: 1:CAS:528:DC%2BD1MXjvVSqsrc%3D, PID: 19149618
-
Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des. 2009;15:272–89.
-
(2009)
Curr Pharm Des
, vol.15
, pp. 272-289
-
-
Protogerou, A.D.1
Stergiou, G.S.2
Vlachopoulos, C.3
Blacher, J.4
Achimastos, A.5
-
42
-
-
77952950611
-
Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study
-
COI: 1:CAS:528:DC%2BC3cXmt1altLY%3D, PID: 20404219
-
Boutouyrie P, Achouba A, Trunet P, Laurent S, for the, ETG. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study. Hypertension. 2010;55:1314–22.
-
(2010)
Hypertension
, vol.55
, pp. 1314-1322
-
-
Boutouyrie, P.1
Achouba, A.2
Trunet, P.3
Laurent, S.4
-
43
-
-
0035569613
-
Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men
-
COI: 1:CAS:528:DC%2BD3MXksFOltrs%3D, PID: 11408390
-
Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension. 2001;37:1429–33.
-
(2001)
Hypertension
, vol.37
, pp. 1429-1433
-
-
Kelly, R.P.1
Millasseau, S.C.2
Ritter, J.M.3
Chowienczyk, P.J.4
-
44
-
-
84938347412
-
Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure
-
COI: 1:CAS:528:DC%2BC2MXpslGgsLg%3D, PID: 25987662
-
Dudenbostel T, Acelajado MC, Pisoni R, Li P, Oparil S, Calhoun DA. Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure. Hypertension. 2015;66:126–33.
-
(2015)
Hypertension
, vol.66
, pp. 126-133
-
-
Dudenbostel, T.1
Acelajado, M.C.2
Pisoni, R.3
Li, P.4
Oparil, S.5
Calhoun, D.A.6
-
45
-
-
85010025313
-
Quantification of heart rate dependency of aortic pulse wave velocity
-
Tan I, Spronck B, Delhaas T, Reesink K, Kiat H, Barin E, et al. Quantification of heart rate dependency of aortic pulse wave velocity. J Hypertens. 2016;34(Suppl 2):e57.
-
(2016)
J Hypertens
, vol.34
-
-
Tan, I.1
Spronck, B.2
Delhaas, T.3
Reesink, K.4
Kiat, H.5
Barin, E.6
-
46
-
-
0034657775
-
The influence of heart rate on augmentation index and central arterial pressure in humans
-
COI: 1:CAS:528:DC%2BD3cXjvFGisr8%3D, PID: 10811742
-
Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525:263–70.
-
(2000)
J Physiol
, vol.525
, pp. 263-270
-
-
Wilkinson, I.B.1
MacCallum, H.2
Flint, L.3
Cockcroft, J.R.4
Newby, D.E.5
Webb, D.J.6
-
47
-
-
68549104289
-
Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data
-
COI: 1:CAS:528:DC%2BD1MXosFWiurc%3D, PID: 19564542
-
Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, et al. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension. 2009;54:375–83.
-
(2009)
Hypertension
, vol.54
, pp. 375-383
-
-
Avolio, A.P.1
Van Bortel, L.M.2
Boutouyrie, P.3
Cockcroft, J.R.4
McEniery, C.M.5
Protogerou, A.D.6
-
48
-
-
84925855696
-
Non-invasive estimation of aortic blood pressures: a close look at current devices and methods
-
COI: 1:CAS:528:DC%2BC2MXhtVSrtLk%3D, PID: 25341862
-
Millasseau S, Agnoletti D. Non-invasive estimation of aortic blood pressures: a close look at current devices and methods. Curr Pharm Des. 2015;21:709–18.
-
(2015)
Curr Pharm Des
, vol.21
, pp. 709-718
-
-
Millasseau, S.1
Agnoletti, D.2
-
49
-
-
84892367308
-
Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study
-
COI: 1:CAS:528:DC%2BC2cXisVeiug%3D%3D, PID: 24060891
-
Sharman JE, Marwick TH, Gilroy D, Otahal P, Abhayaratna WP, Stowasser M. Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study. Hypertension. 2013;62:1138–45.
-
(2013)
Hypertension
, vol.62
, pp. 1138-1145
-
-
Sharman, J.E.1
Marwick, T.H.2
Gilroy, D.3
Otahal, P.4
Abhayaratna, W.P.5
Stowasser, M.6
-
50
-
-
84960433721
-
Guiding hypertension management using central blood pressure: effect of medication withdrawal on left ventricular function
-
PID: 26152757
-
Kosmala W, Marwick TH, Stanton T, Abhayaratna WP, Stowasser M, Sharman JE. Guiding hypertension management using central blood pressure: effect of medication withdrawal on left ventricular function. Am J Hypertens. 2016;29:319–25.
-
(2016)
Am J Hypertens
, vol.29
, pp. 319-325
-
-
Kosmala, W.1
Marwick, T.H.2
Stanton, T.3
Abhayaratna, W.P.4
Stowasser, M.5
Sharman, J.E.6
-
51
-
-
77958502874
-
Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice
-
COI: 1:CAS:528:DC%2BC3cXht1yktb%2FP, PID: 20683338
-
Ait-Oufella H, Collin C, Bozec E, Laloux B, Ong KT, Dufouil C, et al. Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. J Hypertens. 2010;28:2336–41.
-
(2010)
J Hypertens
, vol.28
, pp. 2336-2341
-
-
Ait-Oufella, H.1
Collin, C.2
Bozec, E.3
Laloux, B.4
Ong, K.T.5
Dufouil, C.6
-
52
-
-
84921441065
-
Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers
-
COI: 1:CAS:528:DC%2BC2MXhsF2mtLk%3D, PID: 25061978
-
Barbaro NR, Fontana V, Modolo R, De Faria AP, Sabbatini AR, Fonseca FH, et al. Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers. Blood Press. 2015;24:7–13.
-
(2015)
Blood Press
, vol.24
, pp. 7-13
-
-
Barbaro, N.R.1
Fontana, V.2
Modolo, R.3
De Faria, A.P.4
Sabbatini, A.R.5
Fonseca, F.H.6
-
53
-
-
84856483461
-
Vascular stiffness and endothelial dysfunction: correlations at different levels of blood pressure
-
COI: 1:CAS:528:DC%2BC38XhtlKnsrg%3D, PID: 22029740
-
Figueiredo VN, Yugar-Toledo JC, Martins LC, Martins LB, de Faria AP, de Haro Moraes C, et al. Vascular stiffness and endothelial dysfunction: correlations at different levels of blood pressure. Blood Press. 2012;21:31–8.
-
(2012)
Blood Press
, vol.21
, pp. 31-38
-
-
Figueiredo, V.N.1
Yugar-Toledo, J.C.2
Martins, L.C.3
Martins, L.B.4
de Faria, A.P.5
de Haro Moraes, C.6
-
54
-
-
84994096992
-
Increased circulating tissue inhibitor of metalloproteinase-2 is associated with resistant hypertension
-
COI: 1:CAS:528:DC%2BC28Xhs1GqsrrL
-
Sabbatini AR, Barbaro NR, de Faria AP, Modolo R, Ritter AM, Pinho C, et al. Increased circulating tissue inhibitor of metalloproteinase-2 is associated with resistant hypertension. J Clin Hypertens (Greenwich). 2016;18:969–75.
-
(2016)
J Clin Hypertens (Greenwich)
, vol.18
, pp. 969-975
-
-
Sabbatini, A.R.1
Barbaro, N.R.2
de Faria, A.P.3
Modolo, R.4
Ritter, A.M.5
Pinho, C.6
-
55
-
-
84868206319
-
Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension
-
PID: 23062529
-
Brandt MC, Reda S, Mahfoud F, Lenski M, Bohm M, Hoppe UC. Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Am Coll Cardiol. 2012;60:1956–65.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 1956-1965
-
-
Brandt, M.C.1
Reda, S.2
Mahfoud, F.3
Lenski, M.4
Bohm, M.5
Hoppe, U.C.6
-
56
-
-
85051877460
-
-
Hypertension: First description of a potential BP-independent marker of arterial stiffness
-
•• Fortier, C, Sidibé, A, Desjardins, M-P, Marquis, K, De Serres, SA, Mac-Way, F Agharazii, M. Aortic–brachial pulse wave velocity ratio: a blood pressure–independent index of vascular aging. Hypertension 2016. First description of a potential BP-independent marker of arterial stiffness
-
(2016)
C, Sidibé, A, Desjardins, M-P, Marquis, K, De Serres, SA, Mac-Way, F Agharazii, M. Aortic–brachial pulse wave velocity ratio: a blood pressure–independent index of vascular aging
-
-
Fortier1
-
57
-
-
84921559084
-
Aortic-brachial stiffness mismatch and mortality in dialysis population
-
COI: 1:CAS:528:DC%2BC2MXktFWrsA%3D%3D, PID: 25452473
-
Fortier C, Mac-Way F, Desmeules S, Marquis K, De Serres SA, Lebel M, et al. Aortic-brachial stiffness mismatch and mortality in dialysis population. Hypertension. 2015;65:378–84.
-
(2015)
Hypertension
, vol.65
, pp. 378-384
-
-
Fortier, C.1
Mac-Way, F.2
Desmeules, S.3
Marquis, K.4
De Serres, S.A.5
Lebel, M.6
-
58
-
-
80052640920
-
Pharmacological modulation of arterial stiffness
-
COI: 1:CAS:528:DC%2BC3MXhsVOjtr7O, PID: 21902292
-
Boutouyrie P, Lacolley P, Briet M, Regnault V, Stanton A, Laurent S, Mahmud A. Pharmacological modulation of arterial stiffness. Drugs. 2011;71:1689–701.
-
(2011)
Drugs
, vol.71
, pp. 1689-1701
-
-
Boutouyrie, P.1
Lacolley, P.2
Briet, M.3
Regnault, V.4
Stanton, A.5
Laurent, S.6
Mahmud, A.7
-
59
-
-
33645518432
-
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study
-
COI: 1:CAS:528:DC%2BD28XhvVektrg%3D, PID: 16476843
-
Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation. 2006;113:1213–25.
-
(2006)
Circulation
, vol.113
, pp. 1213-1225
-
-
Williams, B.1
Lacy, P.S.2
Thom, S.M.3
Cruickshank, K.4
Stanton, A.5
Collier, D.6
-
60
-
-
84914666833
-
Dose-dependent arterial destiffening and inward remodeling after olmesartan in hypertensives with metabolic syndrome
-
COI: 1:CAS:528:DC%2BC2cXhsFWhurnP, PID: 25001274
-
Laurent S, Boutouyrie P. Dose-dependent arterial destiffening and inward remodeling after olmesartan in hypertensives with metabolic syndrome. Hypertension. 2014;64:709–16.
-
(2014)
Hypertension
, vol.64
, pp. 709-716
-
-
Laurent, S.1
Boutouyrie, P.2
-
61
-
-
33745995415
-
Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives
-
COI: 1:CAS:528:DC%2BD28XlvVSmtrs%3D, PID: 16702490
-
Tropeano AI, Boutouyrie P, Pannier B, Joannides R, Balkestein E, Katsahian S, et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension. 2006;48:80–6.
-
(2006)
Hypertension
, vol.48
, pp. 80-86
-
-
Tropeano, A.I.1
Boutouyrie, P.2
Pannier, B.3
Joannides, R.4
Balkestein, E.5
Katsahian, S.6
-
62
-
-
79955605417
-
Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients
-
COI: 1:CAS:528:DC%2BC3MXlsFKjtbo%3D, PID: 21519280
-
Ong KT, Delerme S, Pannier B, Safar ME, Benetos A, Laurent S, Boutouyrie P. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens. 2011;29:1034–42.
-
(2011)
J Hypertens
, vol.29
, pp. 1034-1042
-
-
Ong, K.T.1
Delerme, S.2
Pannier, B.3
Safar, M.E.4
Benetos, A.5
Laurent, S.6
Boutouyrie, P.7
-
63
-
-
0035916234
-
Impact of aortic stiffness attenuation on survival of patients in end- stage renal failure
-
COI: 1:STN:280:DC%2BD3M3msFajtw%3D%3D, PID: 11181474
-
Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end- stage renal failure. Circulation. 2001;103:987–92.
-
(2001)
Circulation
, vol.103
, pp. 987-992
-
-
Guerin, A.P.1
Blacher, J.2
Pannier, B.3
Marchais, S.J.4
Safar, M.E.5
London, G.M.6
-
64
-
-
84864286433
-
Arterial stiffness as surrogate markers: needed clinical trials
-
COI: 1:CAS:528:DC%2BC38XhtVCrs7jF, PID: 22733473
-
Laurent S, Briet M, Boutouyrie P. Arterial stiffness as surrogate markers: needed clinical trials. Hypertension. 2012;60:518–22.
-
(2012)
Hypertension
, vol.60
, pp. 518-522
-
-
Laurent, S.1
Briet, M.2
Boutouyrie, P.3
-
65
-
-
0035131479
-
Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats
-
COI: 1:CAS:528:DC%2BD3MXhsl2jurg%3D, PID: 11216994
-
Lacolley P, Safar ME, Lucet B, Ledudal K, Labat C, Benetos A. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol. 2001;37:662–7.
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 662-667
-
-
Lacolley, P.1
Safar, M.E.2
Lucet, B.3
Ledudal, K.4
Labat, C.5
Benetos, A.6
-
66
-
-
0028230940
-
Structural remodeling in hypertensive heart disease and the role of hormones
-
COI: 1:CAS:528:DyaK2cXlslKhu74%3D, PID: 8206620
-
Weber KT, Sun Y, Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension. 1994;23:869–77.
-
(1994)
Hypertension
, vol.23
, pp. 869-877
-
-
Weber, K.T.1
Sun, Y.2
Guarda, E.3
-
67
-
-
0025770664
-
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system
-
COI: 1:STN:280:DyaK3M3kvFChtg%3D%3D, PID: 1828192
-
Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849–65.
-
(1991)
Circulation
, vol.83
, pp. 1849-1865
-
-
Weber, K.T.1
Brilla, C.G.2
-
68
-
-
83455172574
-
A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome
-
Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H, Mysiak A, O’Moore-Sullivan T, Marwick TH. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. J Am Coll Cardiol Img. 2011;4:1239–49.
-
(2011)
J Am Coll Cardiol Img
, vol.4
, pp. 1239-1249
-
-
Kosmala, W.1
Przewlocka-Kosmala, M.2
Szczepanik-Osadnik, H.3
Mysiak, A.4
O’Moore-Sullivan, T.5
Marwick, T.H.6
-
69
-
-
13244267193
-
Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension
-
COI: 1:CAS:528:DC%2BD2MXit1Wms7w%3D, PID: 15691617
-
Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens. 2005;18:50–5.
-
(2005)
Am J Hypertens
, vol.18
, pp. 50-55
-
-
Mahmud, A.1
Feely, J.2
-
70
-
-
3543099842
-
Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure
-
COI: 1:CAS:528:DC%2BD2cXlvF2htbs%3D, PID: 15277317
-
Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation. 2004;110:558–65.
-
(2004)
Circulation
, vol.110
, pp. 558-565
-
-
Mottram, P.M.1
Haluska, B.2
Leano, R.3
Cowley, D.4
Stowasser, M.5
Marwick, T.H.6
-
71
-
-
84876558675
-
Impact of spironolactone on vascular, myocardial, and functional parameters in untreated patients with a hypertensive response to exercise
-
COI: 1:CAS:528:DC%2BC3sXlsV2mt7s%3D, PID: 23412930
-
Hare JL, Sharman JE, Leano R, Jenkins C, Wright L, Marwick TH. Impact of spironolactone on vascular, myocardial, and functional parameters in untreated patients with a hypertensive response to exercise. Am J Hypertens. 2013;26:691–9.
-
(2013)
Am J Hypertens
, vol.26
, pp. 691-699
-
-
Hare, J.L.1
Sharman, J.E.2
Leano, R.3
Jenkins, C.4
Wright, L.5
Marwick, T.H.6
-
72
-
-
84931288451
-
The effects of aldosterone antagonists in patients with resistant hypertension: a meta-analysis of randomized and nonrandomized studies
-
PID: 25801902
-
Dahal K, Kunwar S, Rijal J, Alqatahni F, Panta R, Ishak N, Russell RP. The effects of aldosterone antagonists in patients with resistant hypertension: a meta-analysis of randomized and nonrandomized studies. Am J Hypertens. 2015;28:1376–85.
-
(2015)
Am J Hypertens
, vol.28
, pp. 1376-1385
-
-
Dahal, K.1
Kunwar, S.2
Rijal, J.3
Alqatahni, F.4
Panta, R.5
Ishak, N.6
Russell, R.P.7
-
73
-
-
84947863698
-
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
-
COI: 1:CAS:528:DC%2BC2MXhsFehsbjL, PID: 26414968, Superior BP-lowering action of spironolactone as an add on therapy in RH
-
•• Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386:2059–68. Superior BP-lowering action of spironolactone as an add on therapy in RH
-
(2015)
Lancet
, vol.386
, pp. 2059-2068
-
-
Williams, B.1
MacDonald, T.M.2
Morant, S.3
Webb, D.J.4
Sever, P.5
McInnes, G.6
-
74
-
-
84955561884
-
Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology
-
COI: 1:CAS:528:DC%2BC28Xhs1Cktb4%3D, PID: 26818804
-
Denolle T, Chamontin B, Doll G, Fauvel JP, Girerd X, Herpin D, et al. Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology. J Hum Hypertens. 2016;30:657–63.
-
(2016)
J Hum Hypertens
, vol.30
, pp. 657-663
-
-
Denolle, T.1
Chamontin, B.2
Doll, G.3
Fauvel, J.P.4
Girerd, X.5
Herpin, D.6
-
75
-
-
61849085813
-
Australian Association for Exercise and Sports Science Position Statement on exercise and hypertension
-
PID: 19147407
-
Sharman JE, Stowasser M. Australian Association for Exercise and Sports Science Position Statement on exercise and hypertension. J Sci Med Sport. 2009;12:252–7.
-
(2009)
J Sci Med Sport
, vol.12
, pp. 252-257
-
-
Sharman, J.E.1
Stowasser, M.2
-
76
-
-
0034641653
-
Aging, habitual exercise, and dynamic arterial compliance
-
COI: 1:CAS:528:DC%2BD3cXntFCgt7w%3D, PID: 10982542
-
Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA, Seals DR. Aging, habitual exercise, and dynamic arterial compliance. Circulation. 2000;102:1270–5.
-
(2000)
Circulation
, vol.102
, pp. 1270-1275
-
-
Tanaka, H.1
Dinenno, F.A.2
Monahan, K.D.3
Clevenger, C.M.4
DeSouza, C.A.5
Seals, D.R.6
-
77
-
-
84907597061
-
Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension
-
COI: 1:CAS:528:DC%2BC2cXhsV2lsbnI
-
Diaz KM, Booth JN, Calhoun DA, Irvin MR, Howard G, Safford MM, et al. Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension. The Reasons for Geographic and Racial Differences in Stroke Study. 2014;64:465–71.
-
(2014)
The Reasons for Geographic and Racial Differences in Stroke Study
, vol.64
, pp. 465-471
-
-
Diaz, K.M.1
Booth, J.N.2
Calhoun, D.A.3
Irvin, M.R.4
Howard, G.5
Safford, M.M.6
-
78
-
-
84865508347
-
Aerobic exercise reduces blood pressure in resistant hypertension
-
COI: 1:CAS:528:DC%2BC38Xht1SitbvF, PID: 22802220
-
Dimeo F, Pagonas N, Seibert F, Arndt R, Zidek W, Westhoff TH. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension. 2012;60:653–8.
-
(2012)
Hypertension
, vol.60
, pp. 653-658
-
-
Dimeo, F.1
Pagonas, N.2
Seibert, F.3
Arndt, R.4
Zidek, W.5
Westhoff, T.H.6
-
79
-
-
70349249634
-
Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension
-
COI: 1:CAS:528:DC%2BD1MXpsleksbY%3D
-
Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, Calhoun DA. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension. Results From a Randomized Trial. 2009;54:475–81.
-
(2009)
Results From a Randomized Trial
, vol.54
, pp. 475-481
-
-
Pimenta, E.1
Gaddam, K.K.2
Oparil, S.3
Aban, I.4
Husain, S.5
Dell'Italia, L.J.6
Calhoun, D.A.7
-
80
-
-
84955712114
-
Lifestyle modification for resistant hypertension: the TRIUMPH randomized clinical trial
-
PID: 26542509, e985
-
Blumenthal JA, Sherwood A, Smith PJ, Mabe S, Watkins L, Lin PH, et al. Lifestyle modification for resistant hypertension: the TRIUMPH randomized clinical trial. Am Heart J. 2015;170:986–94. e985
-
(2015)
Am Heart J
, vol.170
, pp. 986-994
-
-
Blumenthal, J.A.1
Sherwood, A.2
Smith, P.J.3
Mabe, S.4
Watkins, L.5
Lin, P.H.6
-
81
-
-
84975745665
-
Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats
-
PID: 27277003
-
Hohl M, Linz D, Fries P, Muller A, Stroeder J, Urban D, et al. Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient rats. J Transl Med. 2016;14:167.
-
(2016)
J Transl Med
, vol.14
, pp. 167
-
-
Hohl, M.1
Linz, D.2
Fries, P.3
Muller, A.4
Stroeder, J.5
Urban, D.6
-
82
-
-
84948955221
-
Effects of renal sympathetic denervation on arterial stiffness and blood pressure control in resistant hypertensive patients: a single centre prospective study
-
Baroni M, Nava S, Giupponi L, Meani P, Panzeri F, Varrenti M, et al. Effects of renal sympathetic denervation on arterial stiffness and blood pressure control in resistant hypertensive patients: a single centre prospective study. High blood pressure & cardiovascular prevention: the official journal of the Italian Society of Hypertension. 2015;22:411–6.
-
(2015)
High blood pressure & cardiovascular prevention: the official journal of the Italian Society of Hypertension
, vol.22
, pp. 411-416
-
-
Baroni, M.1
Nava, S.2
Giupponi, L.3
Meani, P.4
Panzeri, F.5
Varrenti, M.6
-
83
-
-
84964018961
-
Could careful patient selection for renal denervation warrant a positive effect on arterial stiffness and left ventricular mass reduction?
-
PID: 27090039
-
Palionis D, Berukstis A, Misonis N, Ryliskyte L, Celutkiene J, Zakarkaite D, et al. Could careful patient selection for renal denervation warrant a positive effect on arterial stiffness and left ventricular mass reduction? Acta Cardiol. 2016;71:173–83.
-
(2016)
Acta Cardiol
, vol.71
, pp. 173-183
-
-
Palionis, D.1
Berukstis, A.2
Misonis, N.3
Ryliskyte, L.4
Celutkiene, J.5
Zakarkaite, D.6
-
84
-
-
84898731305
-
A controlled trial of renal denervation for resistant hypertension
-
COI: 1:CAS:528:DC%2BC2cXmsVWrurg%3D, PID: 24678939
-
Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393–401.
-
(2014)
N Engl J Med
, vol.370
, pp. 1393-1401
-
-
Bhatt, D.L.1
Kandzari, D.E.2
O'Neill, W.W.3
D'Agostino, R.4
Flack, J.M.5
Katzen, B.T.6
-
85
-
-
84975217376
-
Effect of transcutaneous electrical nerve stimulation on peripheral to central blood pressure ratio in healthy subjects
-
PID: 25640037
-
da Silva ML, Chiappa GR, da Silva VM, Neves LM, de Lima AC, Tomasi FP, et al. Effect of transcutaneous electrical nerve stimulation on peripheral to central blood pressure ratio in healthy subjects. Clin Physiol Funct Imaging. 2016;36:293–7.
-
(2016)
Clin Physiol Funct Imaging
, vol.36
, pp. 293-297
-
-
da Silva, M.L.1
Chiappa, G.R.2
da Silva, V.M.3
Neves, L.M.4
de Lima, A.C.5
Tomasi, F.P.6
-
86
-
-
85007478573
-
Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial
-
PID: 27026087
-
Vilela-Martin JF, Giollo-Junior LT, Chiappa GR, Cipriano-Junior G, Vieira PJ, dos Santos Ricardi F, et al. Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial. Trials. 2016;17:168.
-
(2016)
Trials
, vol.17
, pp. 168
-
-
Vilela-Martin, J.F.1
Giollo-Junior, L.T.2
Chiappa, G.R.3
Cipriano-Junior, G.4
Vieira, P.J.5
dos Santos Ricardi, F.6
-
87
-
-
84938197796
-
Carotid baroreflex activation therapy for resistant hypertension
-
PID: 26149485
-
Victor RG. Carotid baroreflex activation therapy for resistant hypertension. Nat Rev Cardiol. 2015;12:451–63.
-
(2015)
Nat Rev Cardiol
, vol.12
, pp. 451-463
-
-
Victor, R.G.1
-
88
-
-
84916930489
-
Effects of baroreflex activation therapy on arterial stiffness and central hemodynamics in patients with resistant hypertension
-
COI: 1:CAS:528:DC%2BC2cXitVamtL%2FF, PID: 25232758
-
Wallbach M, Lehnig LY, Schroer C, Helms HJ, Luders S, Patschan D, et al. Effects of baroreflex activation therapy on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Hypertens. 2015;33:181–6.
-
(2015)
J Hypertens
, vol.33
, pp. 181-186
-
-
Wallbach, M.1
Lehnig, L.Y.2
Schroer, C.3
Helms, H.J.4
Luders, S.5
Patschan, D.6
-
89
-
-
84960808894
-
Effects of baroreflex activation therapy on ambulatory blood pressure in patients with resistant hypertension
-
COI: 1:CAS:528:DC%2BC28XktVeksrw%3D, PID: 26902491
-
Wallbach M, Lehnig LY, Schroer C, Luders S, Bohning E, Muller GA, et al. Effects of baroreflex activation therapy on ambulatory blood pressure in patients with resistant hypertension. Hypertension. 2016;67:701–9.
-
(2016)
Hypertension
, vol.67
, pp. 701-709
-
-
Wallbach, M.1
Lehnig, L.Y.2
Schroer, C.3
Luders, S.4
Bohning, E.5
Muller, G.A.6
|